NCCN-Lilly RFP on quality of care in gastric cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network announced a collaboration with Eli Lilly and Co. to offer a new opportunity seeking proposals to bridge gaps in care for gastric and gastroesophageal junction cancer patients in the U.S. The Request for Proposals outlines the scope and process that will be followed for the submission of Letters of Intent.

The intent of the RFP is to encourage U.S. organizations to submit LOIs describing concepts and ideas for developing, implementing, and evaluating programs that close clinical practice gaps and improve the quality of care for patients with gastric/GEJ cancer through adherence to evidence-based medicine guidelines, and improved competence and performance of health care providers and health care systems.

NCCN views this collaboration with Lilly as clear recognition of the advantages offered to industry and organizations treating cancer patients through the NCCN Oncology Research Program.

LOIs are due by 11:59 PM EDT, Wednesday, Oct. 24. Please direct questions in writing to Nicole Kamienski at kamienski@nccn.org with the subject line, “2018 Gastric Project.”

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login